Ceftolozane-tazobactam for the Treatment of Respiratory Infections Due to Extensively Drug-resistant Pseudomonas Aeruginosa Among Critically Ill Patients: a Retrospective Study.
Clinical trial NCT04352855 · UNKNOWN
Trial details
- NCT number
- NCT04352855
- Sponsor
- Semmelweis University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-01-18
- Primary completion
- 2020-05-19
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.